Literature DB >> 23800360

Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection.

Ann Usitalo1, Erin Leister, Katherine Tassiopoulos, Susannah Allison, Kathleen Malee, Mary E Paul, Renee Smith, Russell B Van Dyke, George R Seage, Claude A Mellins.   

Abstract

Poor adherence to antiretroviral therapy (ART) contributes to disease progression and emergence of drug-resistant HIV in youth with perinatally acquired HIV infection (PHIV +), necessitating reliable measures of adherence. Although electronic monitoring devices have often been considered the gold-standard assessment in HIV research, they are costly, can overestimate nonadherence and are not practical for routine care. Thus, the development of valid, easily administered self-report adherence measures is crucial for adherence monitoring. PHIV+youth aged 7-16 (n = 289) and their caregivers, enrolled in a multisite cohort study, were interviewed to assess several reported indicators of adherence. HIV-1 RNA viral load (VL) was dichotomized into >/≤ 400 copies/mL. Lower adherence was significantly associated with VL >400 copies/mL across most indicators, including ≥ 1 missed dose in past seven days [youth report: OR = 2.78 (95% CI, 1.46-5.27)]. Caregiver and combined youth/caregiver reports yielded similar results. Within-rater agreement between various adherence indicators was high for both youth and caregivers. Inter-rater agreement on adherence was moderate across most indicators. Age ≥ 13 years and living with biological mother or relative were associated with VL >400 copies/mL. Findings support the validity of caregiver and youth adherence reports and identify youth at risk of poor adherence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800360      PMCID: PMC4190051          DOI: 10.1080/09540121.2013.802280

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  33 in total

Review 1.  Practical and conceptual challenges in measuring antiretroviral adherence.

Authors:  Karina M Berg; Julia H Arnsten
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

2.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

3.  Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study.

Authors:  Jose A Muñoz-Moreno; Carmina R Fumaz; Maria J Ferrer; Albert Tuldrà; Tatiana Rovira; Carme Viladrich; Ramon Bayés; David M Burger; Eugènia Negredo; Bonaventura Clotet
Journal:  AIDS Res Hum Retroviruses       Date:  2007-10       Impact factor: 2.205

4.  Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.

Authors:  Tracy R Glass; Sabina De Geest; Bernard Hirschel; Manuel Battegay; Hansjakob Furrer; Matthias Covassini; Pietro L Vernazza; Enos Bernasconi; Martin Rickenboch; Rainer Weber; Heiner C Bucher
Journal:  Antivir Ther       Date:  2008

5.  Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.

Authors:  Staci Martin; Deborah K Elliott-DeSorbo; Pamela L Wolters; Mary Anne Toledo-Tamula; Gregg Roby; Steve Zeichner; Lauren V Wood
Journal:  Pediatr Infect Dis J       Date:  2007-01       Impact factor: 2.129

6.  Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.

Authors:  Paige L Williams; Deborah Storm; Grace Montepiedra; Sharon Nichols; Betsy Kammerer; Patricia A Sirois; John Farley; Kathleen Malee
Journal:  Pediatrics       Date:  2006-11-13       Impact factor: 7.124

7.  A simple single-item rating scale to measure medication adherence: further evidence for convergent validity.

Authors:  Seth C Kalichman; Christina M Amaral; Connie Swetzes; Michelle Jones; Rene Macy; Moira O Kalichman; Chauncey Cherry
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2009 Nov-Dec

Review 8.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

Authors:  David R Bangsberg
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

Review 9.  Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.

Authors:  Jane M Simoni; Arianna Montgomery; Erin Martin; Michelle New; Penelope A Demas; Sohail Rana
Journal:  Pediatrics       Date:  2007-05-28       Impact factor: 7.124

10.  Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards.

Authors:  Ann E Deschamps; Sabina De Geest; Anne-Mieke Vandamme; Herman Bobbaers; Willy E Peetermans; Eric Van Wijngaerden
Journal:  AIDS Patient Care STDS       Date:  2008-09       Impact factor: 5.078

View more
  35 in total

Review 1.  Self-report measures of medication adherence behavior: recommendations on optimal use.

Authors:  Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen
Journal:  Transl Behav Med       Date:  2015-07-09       Impact factor: 3.046

2.  Youth in transition: life skills among perinatally HIV-infected and HIV-exposed adolescents.

Authors:  Sarah L Pearlstein; Claude A Mellins; Curtis Dolezal; Katherine S Elkington; E Karina Santamaria; Cheng-Shiun Leu; Jennifer E Cruz; Elaine J Abrams
Journal:  J Pediatr Psychol       Date:  2013-10-11

3.  Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.

Authors:  Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

4.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

5.  Behavioral Health and Adult Milestones in Young Adults With Perinatal HIV Infection or Exposure.

Authors:  Elaine J Abrams; Claude A Mellins; Amelia Bucek; Curtis Dolezal; Jeannette Raymond; Andrew Wiznia; Andrea Jurgrau; Mahrukh Bamji; Cheng-Shiun Leu; Yiu Kee Warren Ng
Journal:  Pediatrics       Date:  2018-08-10       Impact factor: 7.124

6.  Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Authors:  Russell B Van Dyke; Kunjal Patel; Ron M Kagan; Brad Karalius; Shirley Traite; William A Meyer; Katherine K Tassiopoulos; George R Seage; Lorna M Seybolt; Sandra Burchett; Rohan Hazra; Robert H Lurie; Ram Yogev; Margaret Ann Sanders; Kathleen Malee; Scott Hunter; William Shearer; Mary Paul; Norma Cooper; Lynnette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Patricia Garvie; James Blood; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Andrew Wiznia; Marlene Burey; Molly Nozyce; Arry Dieudonne; Linda Bettica; Susan Adubato; Janet Chen; Maria Garcia Bulkley; Latreaca Ivey; Mitzie Grant; Katherine Knapp; Kim Allison; Megan Wilkins; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Medea Jones; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Alisa Katai; Jennifer Dunn; Suzanne Paul; Gwendolyn Scott; Patricia Bryan; Elizabeth Willen
Journal:  Clin Infect Dis       Date:  2016-04-07       Impact factor: 9.079

7.  Prospective memory in youth with perinatally-acquired HIV infection.

Authors:  Lynnette L Harris; Miriam C Chernoff; Sharon L Nichols; Paige L Williams; Patricia A Garvie; Cenk Yildirim; Stephen R McCauley; Steven Paul Woods
Journal:  Child Neuropsychol       Date:  2017-08-07       Impact factor: 2.500

8.  Use of Unannounced Telephone Pill Counts to Measure Medication Adherence Among Adolescents and Young Adults Living With Perinatal HIV Infection.

Authors:  Jeannette F Raymond; Amelia Bucek; Curtis Dolezal; Patricia Warne; Stephanie Benson; Elaine J Abrams; Katherine S Elkington; Seth Kalichman; Moira Kalichman; Claude A Mellins
Journal:  J Pediatr Psychol       Date:  2017-10-01

9.  Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.

Authors:  Peter K Olds; Julius P Kiwanuka; Denis Nansera; Yong Huang; Peter Bacchetti; Chengshi Jin; Monica Gandhi; Jessica E Haberer
Journal:  AIDS Care       Date:  2014-12-06

10.  Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth.

Authors:  Julie Alperen; Sean Brummel; Katherine Tassiopoulos; Claude A Mellins; Deborah Kacanek; Renee Smith; George R Seage; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2013-11-13       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.